Skip to main content
. 2018 Feb 2;33(1):479–484. doi: 10.1080/14756366.2018.1428193

Figure 1.

Figure 1.

APs inhibitors; (I) Levamisole (II) Theophylline (III) Aryl sulphonamide-based inhibitors (IV) trizole-based inhibitors (V) Pyrazole-based Inhibitors, (VI) coumarinyl sulphonates.